selected scholarly activity
-
conferences
- DYSGLYCEMIA ASSOCIATED WITH ANTIPSYCHOTIC USE: A SYSTEMATIC REVIEW. International Journal of Neuropsychopharmacology. I26-I27. 2025
- The Impact of Metabolic Dysregulation on Cognition in Mood Disorders: A Systematic Review and Meta-Analysis. Biological Psychiatry. S204-S204. 2023
-
journal articles
- 565. Dysglycemia Associated With Antipsychotic Use: A Systematic Review and Meta-Analysis. Biological Psychiatry. 97:s331. 2025
- Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis. Psychological Medicine. 54:1245-1271. 2024
- Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures. Translational Psychiatry. 14:19. 2024
- Depression in caregivers of patients with schizophrenia: a scoping review.. Social Psychiatry and Psychiatric Epidemiology. 59:1-23. 2024
- Duration of face down positioning following full-thickness macular hole repair: A protocol for a randomized pilot study.. PLoS ONE. 19:e0304566. 2024
- 274. The Impact of Metabolic Dysregulation on Cognition in Mood Disorders: A Systematic Review and Meta-Analysis. Biological Psychiatry. 93:s204. 2023
- Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness - a narrative review.. Expert Opinion on Pharmacotherapy. 24:1823-1832. 2023
- Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series.. Therapeutic Advances in Psychopharmacology. 13:20451253231165169. 2023
- P177. Semaglutide to the Rescue: Real-World Clinical Data in Patients With Antipsychotic-Induced Weight Gain not Responding to Metformin. Biological Psychiatry. 91:s158-s159. 2022
- Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis. Frontiers in Psychiatry. 12:642403. 2021